Related Experiment Video
Updated: Apr 6, 2026
Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
Nanoparticles speckled by ready-to-conjugate lanthanide complexes for multimodal imaging
Vasudevanpillai Biju1, Morihiko Hamada, Kenji Ono
1Health Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 2217-14 Hayashi-Cho, Takamatsu, Kagawa 761-0395, Japan. v.biju@aist.go.jp.
Researchers developed small, multimodal contrast agents by directly conjugating magnetic resonance imaging (MRI) and fluorescence imaging components. These novel nanoparticles offer improved in vivo distribution and clearance for advanced biomedical imaging applications.
Area of Science:
- Biomedical Imaging
- Nanotechnology
- Materials Science
Background:
- Multimodal contrast agents are crucial for biomedical imaging, often using nanoparticles (NPs) like gold, silica, polymers, or liposomes.
- Current large-sized NPs face challenges in in vivo distribution, clearance, and pharmacokinetics, hindering clinical approval.
- There is a need for smaller, more efficient contrast agents combining multiple imaging modalities.
Purpose of the Study:
- To develop novel, small-sized, multimodal contrast agents integrating MRI and fluorescence imaging.
- To overcome the limitations of large nanoparticles in current biomedical imaging agents.
- To evaluate the bioimaging potential of the developed nanoparticles at various biological levels.
Main Methods:
- Directly conjugated novel biotinylated gadolinium(III) coordination complexes to Cadmium Selenide/Zinc Sulfide (CdSe/ZnS) quantum dots (QDs).
- Conjugated terbium(III) to superparamagnetic iron oxide nanoparticles (SPIONs) without using host materials.
- Evaluated the developed lanthanide-speckled fluorescent-magnetic nanoparticles for bioimaging.
Main Results:
- Successfully created small, nanoscale entities combining MRI and fluorescence imaging modalities.
- Demonstrated the potential of these fluorescent-magnetic nanoparticles for bioimaging at single-molecule, cellular, and in vivo levels.
- The direct conjugation method avoided the need for host materials, simplifying preparation.
Conclusions:
- The developed fluorescent-magnetic nanoparticles are promising contrast agents due to their simple preparation and small size.
- These agents offer improved prospects for in vivo distribution and pharmacokinetics compared to larger NPs.
- The study presents a novel approach for creating effective multimodal biomedical imaging agents.
